DK0506853T3 - Anvendelse af GABA-B selektive agonister som antitussive midler - Google Patents

Anvendelse af GABA-B selektive agonister som antitussive midler

Info

Publication number
DK0506853T3
DK0506853T3 DK91902534.6T DK91902534T DK0506853T3 DK 0506853 T3 DK0506853 T3 DK 0506853T3 DK 91902534 T DK91902534 T DK 91902534T DK 0506853 T3 DK0506853 T3 DK 0506853T3
Authority
DK
Denmark
Prior art keywords
gaba
selective agonists
antitussive agents
mammal
antitussive
Prior art date
Application number
DK91902534.6T
Other languages
Danish (da)
English (en)
Inventor
William Kreutner
Donald Bolser
Richard Chapman
Sultan Aziz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0506853T3 publication Critical patent/DK0506853T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK91902534.6T 1989-12-20 1990-12-18 Anvendelse af GABA-B selektive agonister som antitussive midler DK0506853T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/454,786 US5006560A (en) 1989-12-20 1989-12-20 Use of GABA-B selective agonists as anti-tussive agents

Publications (1)

Publication Number Publication Date
DK0506853T3 true DK0506853T3 (da) 1994-08-01

Family

ID=23806078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902534.6T DK0506853T3 (da) 1989-12-20 1990-12-18 Anvendelse af GABA-B selektive agonister som antitussive midler

Country Status (14)

Country Link
US (1) US5006560A (fr)
EP (1) EP0506853B1 (fr)
JP (1) JPH06102630B2 (fr)
KR (1) KR950007208B1 (fr)
AT (1) ATE106725T1 (fr)
AU (1) AU642969B2 (fr)
CA (1) CA2071981C (fr)
DE (1) DE69009778T2 (fr)
DK (1) DK0506853T3 (fr)
ES (1) ES2055587T3 (fr)
FI (1) FI922798A0 (fr)
HU (1) HU212271B (fr)
OA (1) OA09702A (fr)
WO (1) WO1991008740A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229404A (en) * 1988-05-18 1993-07-20 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
US5214054A (en) * 1988-05-18 1993-05-25 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
US5231106A (en) * 1988-05-18 1993-07-27 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
US5182266A (en) * 1990-01-31 1993-01-26 Abbott Laboratories Method for treating renal disease
FR2662354B1 (fr) * 1990-05-23 1994-10-07 Adir Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine.
GB9117716D0 (en) * 1991-08-16 1991-10-02 Lynxvale Ltd Gaba derivatives and their therapeutic application
US6194460B1 (en) * 1995-05-31 2001-02-27 Montefiore Medical Center Composition for treating cough induced by angiotensin converting enzyme inhibitors
DE69738396T2 (de) * 1996-05-24 2008-12-04 Smithkline Beecham Corp. Verwendung von gaba-aufnahme-inhibitoren als mittel gegen husten
CA2327285C (fr) * 1998-05-15 2005-06-14 Warner-Lambert Company Preparations pharmaceutiques stabilisees de derives d'acide gamma-aminobutyrique et procede de fabrication associe
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
EP2354120A1 (fr) 2003-08-20 2011-08-10 XenoPort, Inc. Synthèse de promédicaments a base de carbamate d'acyloxyalkyle et leurs intermédiaires
BRPI0413756A (pt) * 2003-08-20 2006-10-31 Xenoport Inc composto, métodos para tratar ou evitar espasticidade ou um sintoma de espasticidade, doença de refluxo gastro-esofágico, vìcio em droga, vìcio em ou abuso de álcool, ou vìcio em ou abuso de nicotina, e tosse ou êmese em um paciente, e, composição farmacêutica
US7566738B2 (en) * 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US7494985B2 (en) * 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
US7585996B2 (en) * 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
TWI369982B (en) * 2007-01-11 2012-08-11 Xenoport Inc Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
US20090118365A1 (en) * 2007-11-06 2009-05-07 Xenoport, Inc Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain
EP2250148B1 (fr) 2008-01-25 2016-08-17 XenoPort, Inc. Forme cristalline de sels de calcium d'acide (3s)-aminomethyl-5-methyl-hexanoique et ses procedes d'utilisation
ES2601852T3 (es) * 2008-01-25 2017-02-16 Xenoport, Inc. Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso
US7868043B2 (en) 2008-01-25 2011-01-11 Xenoport, Inc. Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US20100137442A2 (en) * 2008-02-01 2010-06-03 Xenoport, Inc. Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
US7989641B2 (en) 2008-08-07 2011-08-02 Xenoport, Inc. Methods of synthesizing N-hydroxysuccinimidyl carbonates
US8299291B2 (en) * 2008-08-07 2012-10-30 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
KR20110117216A (ko) * 2009-03-03 2011-10-26 제노포트 인코포레이티드 Ｒ-바클로펜 전구약물의 서방형 경구 투약 형태
EP2419401A2 (fr) * 2009-04-17 2012-02-22 XenoPort, Inc. DÉRIVÉS D'ACIDE GAMMA-AMINOBUTYRIQUE COMME LIGANDS DES RÉCEPTEURS GABAb
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449645A (de) * 1963-07-09 1968-01-15 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren

Also Published As

Publication number Publication date
CA2071981A1 (fr) 1991-06-21
JPH06102630B2 (ja) 1994-12-14
DE69009778D1 (de) 1994-07-14
DE69009778T2 (de) 1994-09-22
FI922798L (fi) 1992-06-17
WO1991008740A1 (fr) 1991-06-27
JPH05504764A (ja) 1993-07-22
FI922798A7 (fi) 1992-06-17
HU212271B (en) 1996-04-29
US5006560A (en) 1991-04-09
HUT61194A (en) 1992-12-28
OA09702A (en) 1993-08-30
ES2055587T3 (es) 1994-08-16
KR950007208B1 (ko) 1995-07-04
HU9202077D0 (en) 1992-09-28
CA2071981C (fr) 2002-06-25
AU642969B2 (en) 1993-11-04
EP0506853B1 (fr) 1994-06-08
EP0506853A1 (fr) 1992-10-07
ATE106725T1 (de) 1994-06-15
AU7174591A (en) 1991-07-18
FI922798A0 (fi) 1992-06-17
KR920703043A (ko) 1992-12-17

Similar Documents

Publication Publication Date Title
DK0506853T3 (da) Anvendelse af GABA-B selektive agonister som antitussive midler
BR8505386A (pt) Revelador para a revelacao de uma camada de reproducao exposta a luz,que opera negativamente,processo para a preparacao de um molde de impressao,e aplicacao do dito revelador
PT82974B (pt) Processo de sulfatacao de glicosamnoglicanos e de composicoes farmaceuticas que os contem
NO175403C (no) Tampong for medisinske eller hygieniske formål samt fremgangsmåte for fremstilling derav
DK0705095T3 (da) Kombinationer af viskoelastiske midler til brug ved operation
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
BR9005637A (pt) Sistema interativo para guiar o uso de uma ferramenta cirurgica,braco mecanico e metodo de execucao de um procedimento cirurgico
DK0504265T3 (da) Tværbindbare fluorerede polymer-sammensætninger
ES2097782T3 (es) Metodo y composicion para la determinacion de iones sodio en fluidos.
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
DK0731634T3 (da) Anatomisk og biologisk konserveringsmiddel og forbedret balsameringssammensætning og -fremgangsmåde
BR9106122A (pt) Dentifricio inibidor de placa dental
NO891692L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzodiazepiner.
BR9501068A (pt) Composição corante,processo para sua preparação e uso
DK345889A (da) Anvendelse af 5-ht-3-receptorantagonist
SE8304278D0 (sv) Forfarande for behandling av anvend, radioaktiv, organisk jonbytarmassa
ES2038034T3 (es) Composicion acuosa tampon gelificable y su utilizacion para la recuperacion mejorada de petroleo.
DE68917934D1 (de) Fingerabdruck-reagenz.
ES2017086B3 (es) Dispositivo para cerrar fisuras.
SE8206967D0 (sv) Vantskruv
IT8421348A0 (it) Dispositivo per posizionare l'estremita' di una fibra ottica in un manicotto.
ATE74757T1 (de) Phenol enthaltende, fluessige antitussivzusammensetzungen.
ATE4349T1 (de) Mikroskopobjectivfassung.
PH21601A (en) Method of lowering lipid levels
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem